Dr. Hudson Garrett breaks down the findings of a study examining the health outcomes of more than 14,000 patients who underwent a bronchoscopy.

Endoscopy Insights Podcast

Study: Single-Use Bronchoscope Can Reduce Readmission Rates, Infection Risk

Sterile single-use bronchoscopes should be considered to eliminate reprocessing failures, improve overall operational efficiency, and reduce potential acquisition of healthcare-associated infections.

Hospitals that perform bronchoscopies can reduce readmission rates by more than half, and potentially lower costs, by adopting single-use flexible bronchoscopes.

That’s according to a new abstract that was submitted and presented at the recently completed CHEST 2021 annual meeting. The study examined the health outcomes of more than 14,000 patients who underwent a bronchoscopy procedure and found that sterile, single-use bronchoscopes reduced the readmissions rate 53 percent, from 7.7 percent to 3.6 percent, compared with reusable bronchoscopes.

Dr. Hudson Garrett joined Endoscopy Insights to discuss the findings. In our conversation, he talks about why readmission rates are such an important performance metric for hospitals, the key clinical findings he identified in looking at this data, and the larger quality-of-care and patient safety conversations taking place in healthcare.

Garrett is an Ambu consultant.

Show notes:

-------------------------

Endoscopy Insights is a podcast devoted to conversations with thought leaders in flexible and single-use endoscopy. In each episode we’ll explore the ways different clinical and technological innovations are moving the field of endoscopy forward.       

Endoscopy Insights is brought to you by Single-Use Endoscopy, part of the Ambu Learning Center. Ambu has been bringing healthcare solutions of the future to life since 1937.

Subscribe to the Endoscopy Insights Podcast

          

Click here to view all episodes

More Endoscopy Insights Episdoes
Infection Control Risks and Endoscopy
Endoscopy Insights Podcast
What are the challenges, and potential missteps, when it comes to reprocessing bronchoscopes, GI endoscopes and ureteroscopes? We explore these questions and more with Dr. Hudson Garrett.
FDA Investigating Reports of Infections Associated with Reprocessed Urological Endoscopes
Endoscopy Insights Podcast
The FDA is investigating “numerous” medical device reports (MDRs) describing patient infections and other possible contamination issues possibly associated with reprocessed urological endoscopes. Dr. Larry Muscarella talks about the letter to healthcare providers from the FDA.
Best Practices in Endoscope Reprocessing
Endoscopy Insights Podcast
Dr. Larry Muscarella delves into more detail on reprocessing best practices and some of the challenges therein. He also shares his key takeaways from the FDA letter — for clinicians, regulators and healthcare consumers alike.
More From Single-Use Endoscopy
A lack of standardized diagnostic testing for the infection causes delays in diagnosis.

Bronchoscopy Applications

Nontuberculous mycobacterial pulmonary disease, or NTM-PD, is on the rise, especially among the elderly. Cases detected with bronchoscopy showed lower risk of disease progression.

Duodenoscope

Prevention Challenges

A literature review finds current duodenoscope reprocessing measures to be inadequate and explores several promising novel developments.

How Bladder Cancer Patients Should Navigate the BCG Shortage

Public Health

“The most important thing is to have a discussion with your urologist as a first step to see how important is it that you get BCG,” Robert Svatek, MD, said on the Bladder Cancer Matters podcast.